Azenta (NASDAQ: AZTA) grants 17,790 RSUs to Multiomics chief

Rhea-AI Filing Summary

MARTIN WILLIAM E. III reported acquisition or exercise transactions in this Form 4 filing.

Azenta, Inc. granted President Multiomics William E. Martin III an award of 17,790 shares of common stock in the form of restricted stock units. The award is compensation under the company’s Equity Incentive Plan and no cash was paid to receive it.

The units vest over three years, with 33% vesting on April 18, 2027, 33% on April 18, 2028, and the remaining 33% on April 18, 2029. Following this grant, he directly holds 17,790 common shares linked to this award.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MARTIN WILLIAM E. III

Role President Multiomics

Type	Security	Shares	Price	Value
Grant/Award	Common	17,790	$24.24	$431K

Holdings After Transaction: Common — 17,790 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 17,790 shares Grant reference price: $24.24 per share Holdings after grant: 17,790 shares +3 more

6 metrics

RSUs granted 17,790 shares Restricted stock unit award to President Multiomics

Grant reference price $24.24 per share Value reference for 17,790 common shares granted

Holdings after grant 17,790 shares Direct ownership reported following the RSU award

First vesting tranche 33% Vests on April 18, 2027

Second vesting tranche 33% Vests on April 18, 2028

Final vesting tranche 33% Vests on April 18, 2029

Key Terms

restricted stock units, Equity Incentive Plan, vesting, Form 4

4 terms

restricted stock units financial

"Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Incentive Plan financial

"Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan."

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

vesting financial

"The units will vest over three years, 33% on Apriil 18, 2027, 33% on Apriil 18, 2028, and 33% on Apriil 18, 2029."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MARTIN WILLIAM E. III

(Last) (First) (Middle)

C/O AZENTA, INC.

200 SUMMIT DRIVE, 6TH FLOOR

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Azenta, Inc. [ AZTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President Multiomics

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common	04/28/2026		A		17,790(1)	A	$24.24	17,790	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units will vest over three years, 33% on Apriil 18, 2027, 33% on Apriil 18, 2028, and 33% on Apriil 18, 2029.

	/s/Ephraim Starr, Attorney-in-fact for William E. Martin III	04/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Azenta (AZTA) report for William E. Martin III?

Azenta reported a compensation-related grant to President Multiomics William E. Martin III of 17,790 restricted stock units of common stock. The award was made under the company’s Equity Incentive Plan and represents an acquisition of shares rather than an open-market purchase or sale.

How many Azenta (AZTA) shares were granted in this Form 4 filing?

The filing shows a grant of 17,790 restricted stock units of Azenta common stock. These units will convert into shares as they vest over three annual installments, subject to continued service and plan terms, rather than being immediately tradable like shares bought in the open market.

What is the vesting schedule for the Azenta (AZTA) restricted stock units?

The 17,790 restricted stock units vest in three equal installments. According to the filing, 33% vest on April 18, 2027, another 33% on April 18, 2028, and the final 33% on April 18, 2029, creating a three-year, time-based vesting structure for the award.

Was any cash paid for the Azenta (AZTA) restricted stock units granted to Martin?

No cash was paid for these restricted stock units. The footnote states the grant was made under Azenta’s Equity Incentive Plan and that no amount was paid upon grant, confirming this is stock-based compensation rather than a cash-financed share purchase by the executive.

How many Azenta (AZTA) shares does William E. Martin III hold after this grant?

After this award, the Form 4 reports that Martin directly holds 17,790 shares tied to the restricted stock unit grant. This figure reflects his post-transaction position from this filing and highlights that the entire reported holding results from this single equity compensation grant.

Is the Azenta (AZTA) Form 4 transaction a market buy or sell?

The transaction is neither an open-market buy nor an open-market sale. It is coded as a grant or award acquisition, meaning Azenta granted 17,790 restricted stock units to Martin as compensation under its Equity Incentive Plan, with shares vesting over three years rather than being immediately traded.